Franklin Pharmaceuticals India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 31 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Net Worth -4.00%
- Total Assets %
About Franklin Pharmaceuticals India
Franklin Pharmaceuticals India Private Limited (FPIPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 December 1993 and has a history of 31 years and one month. Its registered office is in Ludhiana, Punjab, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ajay Sareen, Krishan Sareen, Anju Thapar, and One other member serve as directors at the Company.
Company Details
-
Location
Ludhiana, Punjab, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24231PB1993PTC014063
-
Company No.
014063
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
29 Dec 1993
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Franklin Pharmaceuticals India?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajay Sareen
|
Director | 21-Apr-2019 | Current |
|
Krishan Sareen
|
Director | 21-Apr-2019 | Current |
|
Anju Thapar
|
Director | 06-Jun-2018 | Current |
|
Akshay Sareen
|
Director | 06-Jun-2018 | Current |
Financial Performance of Franklin Pharmaceuticals India.
Franklin Pharmaceuticals India Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Franklin Pharmaceuticals India?
In 2019, Franklin Pharmaceuticals India had a promoter holding of 54.00% and a public holding of 46.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Franklin Laboratories India Pvt LtdAjay Sareen, Krishan Sareen and 2 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Franklin Pharmaceuticals India?
Franklin Pharmaceuticals India has a workforce of 91 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Franklin Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Franklin Pharmaceuticals India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.